ORIC Chart
- 52-Week Range: $2.70 - $25.22
- Market Capitalization: $128.70M
- Short Percentage: 0%
- Target Price: $13.00
- Shares Outstanding: 39.48M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ORIC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 17th
- ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational UpdateGlobeNewsWire | May 9th
- ORIC Pharmaceuticals, Inc.'s (ORIC) CEO Jacob Chacko on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 21st
- ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming MilestonesGlobeNewsWire | January 10th
- ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 4th
Company Info
Website: https://www.oricpharma.com
Address: 240 East Grand Avenue, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 78
Address: 240 East Grand Avenue, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 78
$ORIC yeeeeeee haw
$ORIC this is just going to go up forever
$ORIC BULLS ALPHA
BEARS BETA
$ORIC when's the offering?
$ORIC we just getting started
$ORIC the time is near
$ORIC It's happening!
$ORIC Don't hold!!! Buy it
$ORIC man this will be good in coming weeks